Urine ACR
[Urine ACR]
EPTIS Ringversuch Nr. 1177324 | Letze Änderung 2024-09-24 | URL: https://www.eptis.bam.de/pts1177324 https://www.eptis.bam.de/pts1177324
| Name des Anbieters | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Name des Anbieters | Weqas Weqas | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Ansässig in | United Kingdom | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Sprache(n) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anmerkungen | The Urine Chemistry programme is specifically designed to assess the performance of the routine Clinical Chemistry laboratory to analyse basic core tests in urine (including 24hr urine samples). These urine tests cover a wide application of disease states, such as in the investigation of renal function, and various endocrine disorders. Three levels of fresh filtered human urine are distributed monthly for testing of 14 Urine chemistry measurands along with 2 calculated parameters, Albumin/Creatinine and Protein/Creatinine ratios. Separate acidified samples are provided for Calcium, Phosphate and Magnesium analysis to enhance stability. Fresh human urine is used as the matrix, with additional samples spiked with the measurand to achieve the appropriate clinical range. The samples are distributed on more than one occasion which allows for the assessment of between batch imprecision. Seventy two samples are provided over the course of a year. Key Features: - Fresh endogenous and spiked urine samples distributed. - Separate 1mL acidified samples supplied for Calcium, Magnesium and Phosphate for enhanced stability. - Samples assess both laboratory and method performance, including linearity, bias, within and between batch imprecision. - Liquid human Urine samples requiring no pre-analytical preparation. - Includes endogenous samples commutable across all testing platforms. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/eqa/urine-chemistry/ or contact@weqas.com | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Klassifizierung | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Produktgruppen |
Health care / medical devices
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Technische Einzelheiten | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ringversuchsziele | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | The programme assesses both laboratory and method performance, including linearity, bias, within and between batch imprecision. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS on the basis of ISO/IEC 17043 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Weitere Ziele | validation of testing methods | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Teilnehmerzahl | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043 |
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kosten | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (Frequency: Monthly. Samples: 3 x 2.5mL + 3 x 0.5mL acidified. ) | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2002 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.